SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zim Laboratories informs about newspaper advertisements

06 Jun 2026 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Zim Laboratories has submitted a copy of newspaper advertisements published in respect of 42nd Annual General Meeting of the Company scheduled to be held on Monday, 29th June, 2026 in the Newspapers, The Financial Express (English) all India Edition, Indian Express (English) Nagpur Edition and Loksatta (Marathi).

The above information is a part of company’s filings submitted to BSE.  

Zim Laboratories Share Price

108.60 5.15 (4.98%)
09-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1779.40
Dr. Reddys Lab 1268.75
Cipla 1376.75
Zydus Lifesciences 1105.75
Lupin 2263.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×